(15206898), H. J. J., (15053070), G. H., (15206901), A. W. M., (15206904), Z. M., (15019395), E. A. R., (15206907), T. H., . . . (15044781), E. R. P. (2025). Supplementary Tables 1 from A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy.
Chicago Style (17th ed.) Citation(15206898), H. Josh Jang, et al. Supplementary Tables 1 from A Phase II Trial of Guadecitabine Plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing After Initial Immune Checkpoint Inhibitor Therapy. 2025.
MLA引文(15206898), H. Josh Jang, et al. Supplementary Tables 1 from A Phase II Trial of Guadecitabine Plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing After Initial Immune Checkpoint Inhibitor Therapy. 2025.